| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9987976 | Thrombosis Research | 2018 | 7 Pages |
Abstract
Our findings demonstrated that the anti-c-Mpl antibody represents a novel indicator of poor prognosis and may be a potential therapeutic target in ITP.
Keywords
IVIgMNCsTPODXMCBCRTXTTRMAIPAtime to responseMDSAMLhealthy donorIntravenous immunoglobulinno responseRheumatic diseaseImmune thrombocytopeniaThrombopoietinEnzyme-linked immunosorbent assayELISADexamethasoneRituximabMononuclear cellsmyelodysplastic syndromecomplete blood countacute myeloid leukemiaSystemic lupus erythematosusSLEITPResponsecomplete responseprognosisaplastic anemiaGlycoprotein
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Fang-Miao Jing, Xiao-Lin Zhang, Fan-Li Meng, Xiao-Ming Liu, Yan Shi, Ping Qin, Lin Wang, Hai Zhou, Yu Hou, Qiang Song, Jun Peng, Ming Hou,